Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Articles by Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Latest Updated Articles
Increased Survival Outcomes with Switch Maintenance in mUCPublished: August 26th 2020 | Updated:
Changing the Standard of Care in Metastatic Bladder CancerPublished: August 26th 2020 | Updated:
Safety Data from JAVELIN Bladder 100Published: August 26th 2020 | Updated:
Sequencing Considerations in mUC after Frontline IOPublished: August 26th 2020 | Updated:
Current Status of Therapy: Metastatic Urothelial CancerPublished: August 26th 2020 | Updated:
PD-L1 Expression in Metastatic Urothelial CancerPublished: August 26th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5